Population Health and Disparities
Our work in Population Health and Disparities
-
Use of Prescription Medications with Cardiovascular Adverse Effects Among Older Adults in the United States
Schaeffer experts examined the association between the concurrent use of prescription medications with known risk of a major adverse cardiovascular event (MACE) (“MACE medications”) and the risk of such events among older adults.
Categorized in -
Racial Disparities in Accessing Treatment for Substance Use Highlights Work to Be Done
Older Americans are increasingly seeking treatment for substance use disorders with older Black Americans who start treatment being much more likely to have their treatment terminated and not finish compared to white adults.
Categorized in -
Biomedical Expert Designs Health Dataset Representing All Demographic Groups
Although big data is revolutionizing healthcare, its potential has been limited by underrepresentation of vulnerable populations, including marginalized racial and socioeconomic groups that are at higher risk for poor health outcomes.
Categorized in -
Before Prescribing Opioids, Draft a Deprescribing Plan
To get past the allure of continued and often troublesome opioid use patterns, patients and doctors need a plan in hand before the first opioid is ever used.
Categorized in -
Frameworks for Protecting Workers and the Public from Inhalation Hazards
A National Academies committee will consider the oversight and regulatory processes needed to ensure the public and such workers have access to effective respiratory protective devices and guidance on their use to mitigate exposures to inhalation hazards—including those arising during disasters and public health emergencies.
-
The Great Divide: Education, Despair, and Death
Deaths of despair, morbidity, and emotional distress continue to rise in the United States, largely borne by those without a college degree—the majority of American adults—for many of whom the economy and society are no longer delivering.
Categorized in -
Schaeffer Expert Warns of Lax Regulation of U.S. Cannabis Market at U.N. Event
Rosalie Liccardo Pacula presented findings at the U.N. Commission on Narcotic Drugs side event.
Categorized in -
A Conversation on the Biden-Harris Administration’s Drug Control Policy
The USC Schaeffer Center and the Institute for Addiction Science will host a conversation with White House Director of National Drug Control Policy, Dr. Rahul Gupta.
-
Projecting Future Health and Service Use Among Older People in Ireland: An Overview of a Dynamic Microsimulation Model in The Irish Longitudinal Study on Ageing
Demographic ageing is a population health success story but poses unprecedented policy challenges in the 21st century. Policymakers must prepare health systems, economies and societies for these challenges. Policy choices can be usefully informed by models that evaluate outcomes and trade-offs in advance under different scenarios.
-
Changes in the Availability of Medications for Opioid Use Disorder in Prisons and Jails in the United States During the COVID-19 Pandemic
During the COVID-19 pandemic, federal agencies relaxed buprenorphine prescribing restrictions including for incarcerated individuals.
Categorized in